Skip to main content

Table 1 Patient characteristics

From: A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice

Variable Categories   Number of patients (%)*
Patients in study    53 (100)
Mesothelioma subtype Epitheloid   46 (87)
  Sarcomatoid   1 (2)
  Biphasic   5 (9)
  Unknown   1 (2)
Sex Male   36 (68)
  Female   17 (32)
Age Mean   69 (range 24–90)
Performance status 0   4 (8)
  1   28 (53)
  2   6 (11)
  3   2 (4)
  Unknown   13 (25)
Chemotherapy lines including current 0   14 (26)
1   36 (68)
2   2 (4)
3   1 (2)
Chemotherapy status while on the study Given   30 (56.6)
   Mesomark prior to CT 12 (40)
   Mesomark post CT 18 (60)
  Not given   23 (43)
  1. *Percentages rounded up to the nearest 1.0%; Mesomark, serum mesothelin ELISA test; CT, chemotherapy.